Literature DB >> 35422159

Re-randomisation trials in multi-episode settings: Estimands and independence estimators.

Brennan C Kahan1,2, Ian R White2, Richard Hooper1, Sandra Eldridge1.   

Abstract

Often patients may require treatment on multiple occasions. The re-randomisation design can be used in such multi-episode settings, as it allows patients to be re-enrolled and re-randomised for each new treatment episode they experience. We propose a set of estimands that can be used in multi-episode settings, focusing on issues unique to multi-episode settings, namely how each episode should be weighted, how the patient's treatment history in previous episodes should be handled, and whether episode-specific effects or average effects across all episodes should be used. We then propose independence estimators for each estimand, and show the manner in which many re-randomisation trials have been analysed in the past (a simple comparison between all intervention episodes vs. all control episodes) corresponds to a per-episode added-benefit estimand, that is, the average effect of the intervention across all episodes, over and above any benefit conferred from the intervention in previous episodes. We show this estimator is generally unbiased, and describe when other estimators will be unbiased. We conclude that (i) consideration of these estimands can help guide the choice of which analysis method is most appropriate; and (ii) the re-randomisation design with an independence estimator can be a useful approach in multi-episode settings.

Entities:  

Keywords:  Estimand; informative cluster size; multi-episode setting; randomised trial; re-randomisation design

Year:  2022        PMID: 35422159      PMCID: PMC9251752          DOI: 10.1177/09622802221094140

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   2.494


  27 in total

1.  Treatment effect quantification for time-to-event endpoints-Estimands, analysis strategies, and beyond.

Authors:  Kaspar Rufibach
Journal:  Pharm Stat       Date:  2018-11-26       Impact factor: 1.894

2.  Granulocyte colony-stimulating factor in established febrile neutropenia: a randomized study of pediatric patients.

Authors:  P L Mitchell; B Morland; M C Stevens; G Dick; D Easlea; L C Meyer; C R Pinkerton
Journal:  J Clin Oncol       Date:  1997-03       Impact factor: 44.544

3.  Treatment estimands in clinical trials of patients hospitalised for COVID-19: ensuring trials ask the right questions.

Authors:  Brennan C Kahan; Tim P Morris; Ian R White; Conor D Tweed; Suzie Cro; Darren Dahly; Tra My Pham; Hanif Esmail; Abdel Babiker; James R Carpenter
Journal:  BMC Med       Date:  2020-09-09       Impact factor: 8.775

4.  Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial.

Authors:  Pieter F van der Meer; Paula F Ypma; Nan van Geloven; Joost A van Hilten; Rinie J van Wordragen-Vlaswinkel; Okke Eissen; Jaap J Zwaginga; Michael Trus; Erik A M Beckers; Peter Te Boekhorst; Alan Tinmouth; Yulia Lin; Cyrus Hsia; David Lee; Philip J Norris; Raymond P Goodrich; Anneke Brand; Tor Hervig; Nancy M Heddle; Johanna G van der Bom; Jean-Louis H Kerkhoffs
Journal:  Blood       Date:  2018-05-17       Impact factor: 22.113

5.  A Randomized Trial of Prenatal n-3 Fatty Acid Supplementation and Preterm Delivery.

Authors:  Maria Makrides; Karen Best; Lisa Yelland; Andrew McPhee; Shao Zhou; Julie Quinlivan; Jodie Dodd; Elinor Atkinson; Huda Safa; Jacqueline van Dam; Nisha Khot; Gustaaf Dekker; Monika Skubisz; Amanda Anderson; Beth Kean; Anneka Bowman; Carly McCallum; Kara Cashman; Robert Gibson
Journal:  N Engl J Med       Date:  2019-09-12       Impact factor: 91.245

6.  Re-randomization increased recruitment and provided similar treatment estimates as parallel designs in trials of febrile neutropenia.

Authors:  Brennan C Kahan; Tim P Morris; Erica Harris; Rupert Pearse; Richard Hooper; Sandra Eldridge
Journal:  J Clin Epidemiol       Date:  2018-02-08       Impact factor: 6.437

7.  TILT: Time-Lapse Imaging Trial-a pragmatic, multi-centre, three-arm randomised controlled trial to assess the clinical effectiveness and safety of time-lapse imaging in in vitro fertilisation treatment.

Authors:  Priya Bhide; Arasaratnam Srikantharajah; Doris Lanz; Julie Dodds; Bonnie Collins; Javier Zamora; David Chan; Shakila Thangaratinam; Khalid S Khan
Journal:  Trials       Date:  2020-07-01       Impact factor: 2.279

Review 8.  Review of methods for handling confounding by cluster and informative cluster size in clustered data.

Authors:  Shaun Seaman; Menelaos Pavlou; Andrew Copas
Journal:  Stat Med       Date:  2014-08-04       Impact factor: 2.373

9.  Azithromycin for episodes with asthma-like symptoms in young children aged 1-3 years: a randomised, double-blind, placebo-controlled trial.

Authors:  Jakob Stokholm; Bo L Chawes; Nadja H Vissing; Elín Bjarnadóttir; Tine M Pedersen; Rebecca K Vinding; Ann-Marie M Schoos; Helene M Wolsk; Sunna Thorsteinsdóttir; Henrik W Hallas; Lambang Arianto; Susanne Schjørring; Karen A Krogfelt; Thea K Fischer; Christian B Pipper; Klaus Bønnelykke; Hans Bisgaard
Journal:  Lancet Respir Med       Date:  2015-12-17       Impact factor: 30.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.